Porcilis® Ery+Parvo+Lepto
Erysipelas, parvovirosis and leptospirosis are widely spread infectious diseases that impact animal welfare and cause considerable losses to pig producers. Parvovirosis and leptospirosis are especially important for breeding units as they affect the sow fertility and development of pregnancy. Leptospirosis is also an important zoonosis so protecting the pig herds against it is crucial.
Presentation
Homogenous white to nearly white suspension after shaking.
Active ingredients
Each dose of 2 ml contains:
Inactivated strains of:
- Erysipelothrix rhusiopathiae, serotype 2 (strain M2) ≥ 1 ppd1
- Porcine parvovirus (strain 014) ≥ 130 U2
- Leptospira interrogans serogroup Canicola serovar Portland-Vere (strain Ca-12-000) ≥ 2816 U2
- Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001) ≥ 210 U2
- Leptospira interrogans serogroup Australis serovar Bratislava (strain As-05-073) ≥ 1310 U2
- Leptospira kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005) ≥ 648 U2
- Leptospira interrogans serogroup Pomona serovar Pomona (strain Po-01-000) ≥ 166 U2
- Leptospira santarosai serogroup Tarassovi serovar Gatuni (strain S1148/02) ≥ 276 U2
Target species
Pigs for reproduction
Indications for use
For the active immunisation of pigs:
- to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2.
- to reduce transplacental infection, viral load and foetal mortality caused by Porcine parvovirus.
- to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), infection and bacterial excretion caused by L. interrogans serogroup Canicola serovar Canicola.
- to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), severity of infection and foetal mortality caused by L. interrogans serogroup Pomona serovar Pomona.
- to reduce infection caused by L. interrogans serogroup Icterohaemorrhagiae serovars Copenhageni and Icterohaemorrhagiae, L. interrogans serogroup Australis serovar Bratislava, L. kirschneri serogroup Grippotyphosa serovars Grippotyphosa and Bananal/Liangguang, L. weilii serogroup Tarassovi serovar Vughia and L. borgpetersenii serogroup Tarassovi serovar Tarassovi.
Withdrawal periods
Pigs: meat 0 days
Packaging
PET-vial closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap.
Pack sizes:
1 vial of 20 ml (10 doses), 50 ml (25 doses), 100 ml (50 doses) or 250 ml (125 doses) packed in a cardboard box.
Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: November 2025
References
1. Pig protective dose as compared to a reference preparation known to be protective in pigs.
2. As determined in the in vitro antigenic mass ELISA potency test.